| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-170 |
Sentence |
denotes |
Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non-inferiority trial. |
| T2 |
171-182 |
Sentence |
denotes |
BACKGROUND: |
| T3 |
183-336 |
Sentence |
denotes |
Acute ankle sprains are common and activity limiting injuries, and topical diclofenac gel has proven efficacy in alleviating pain and restoring function. |
| T4 |
337-472 |
Sentence |
denotes |
This trial aimed to compare a topical natural agent, Traumeel with topical diclofenac gel (1%) in the management of acute ankle sprain. |
| T5 |
473-481 |
Sentence |
denotes |
METHODS: |
| T6 |
482-682 |
Sentence |
denotes |
This prospective, multicentre, randomised, blinded, active-control and non-inferiority study involved 449 physically active adults sustaining unilateral grade 1 or 2 ankle sprain within the past 24 h. |
| T7 |
683-921 |
Sentence |
denotes |
Participants were randomised to receive 2 g of Traumeel ointment (T-O) (n = 152) or Traumeel gel (T-G) (n = 150) or diclofenac gel (D-G) (n = 147), administered topically to the ankle three times a day for 14 days, with 6-weeks follow up. |
| T8 |
922-930 |
Sentence |
denotes |
RESULTS: |
| T9 |
931-1076 |
Sentence |
denotes |
Day 7 median percentage reductions in Visual Analogue Scale pain score were 60.6%, 71.1% and 68.9% for the T-O, T-G and D-G groups, respectively. |
| T10 |
1077-1185 |
Sentence |
denotes |
Total pain relief was reported by 12 (8.5%), 7 (5.0%) and 8 (5.9%) participants in each group, respectively. |
| T11 |
1186-1356 |
Sentence |
denotes |
Median improvements in Foot and Ankle Ability Measure Activities of Daily Living subscale score were 26.2, 26.2 and 25.0 points for T-O, T-G and D-G groups, respectively. |
| T12 |
1357-1521 |
Sentence |
denotes |
Mann-Whitney effect sizes and lower bound confidence intervals demonstrated non-inferiority of Traumeel vs. diclofenac for reducing pain and functional improvement. |
| T13 |
1522-1597 |
Sentence |
denotes |
At 6 weeks, participants reported total pain relief and normal functioning. |
| T14 |
1598-1666 |
Sentence |
denotes |
Adverse events (n = 43) were reported by 31/447 participants (6.9%). |
| T15 |
1667-1706 |
Sentence |
denotes |
Treatments were equally well tolerated. |
| T16 |
1707-1848 |
Sentence |
denotes |
CONCLUSIONS: T-O and T-G decreased pain and improved joint function to the same extent as D-G in acute ankle sprain, and were well tolerated. |
| T1 |
0-170 |
Sentence |
denotes |
Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non-inferiority trial. |
| T2 |
171-182 |
Sentence |
denotes |
BACKGROUND: |
| T3 |
183-336 |
Sentence |
denotes |
Acute ankle sprains are common and activity limiting injuries, and topical diclofenac gel has proven efficacy in alleviating pain and restoring function. |
| T4 |
337-472 |
Sentence |
denotes |
This trial aimed to compare a topical natural agent, Traumeel with topical diclofenac gel (1%) in the management of acute ankle sprain. |
| T5 |
473-481 |
Sentence |
denotes |
METHODS: |
| T6 |
482-682 |
Sentence |
denotes |
This prospective, multicentre, randomised, blinded, active-control and non-inferiority study involved 449 physically active adults sustaining unilateral grade 1 or 2 ankle sprain within the past 24 h. |
| T7 |
683-921 |
Sentence |
denotes |
Participants were randomised to receive 2 g of Traumeel ointment (T-O) (n = 152) or Traumeel gel (T-G) (n = 150) or diclofenac gel (D-G) (n = 147), administered topically to the ankle three times a day for 14 days, with 6-weeks follow up. |
| T8 |
922-930 |
Sentence |
denotes |
RESULTS: |
| T9 |
931-1076 |
Sentence |
denotes |
Day 7 median percentage reductions in Visual Analogue Scale pain score were 60.6%, 71.1% and 68.9% for the T-O, T-G and D-G groups, respectively. |
| T10 |
1077-1185 |
Sentence |
denotes |
Total pain relief was reported by 12 (8.5%), 7 (5.0%) and 8 (5.9%) participants in each group, respectively. |
| T11 |
1186-1356 |
Sentence |
denotes |
Median improvements in Foot and Ankle Ability Measure Activities of Daily Living subscale score were 26.2, 26.2 and 25.0 points for T-O, T-G and D-G groups, respectively. |
| T12 |
1357-1521 |
Sentence |
denotes |
Mann-Whitney effect sizes and lower bound confidence intervals demonstrated non-inferiority of Traumeel vs. diclofenac for reducing pain and functional improvement. |
| T13 |
1522-1597 |
Sentence |
denotes |
At 6 weeks, participants reported total pain relief and normal functioning. |
| T14 |
1598-1666 |
Sentence |
denotes |
Adverse events (n = 43) were reported by 31/447 participants (6.9%). |
| T15 |
1667-1706 |
Sentence |
denotes |
Treatments were equally well tolerated. |
| T16 |
1707-1848 |
Sentence |
denotes |
CONCLUSIONS: T-O and T-G decreased pain and improved joint function to the same extent as D-G in acute ankle sprain, and were well tolerated. |